Category: Biopharmaceuticals
Global Biopharmaceuticals
-
Biologics Contract Development & Manufacturing Organization Market by Type (Mammalian, Non-mammalian), Product Type (Biologics, Biosimilars), Disease Indication, Service Type, End-User - Global Forecast 2024-2030
... at USD 9.88 billion in 2023 and expected to reach USD 10.59 billion in 2024, at a CAGR 7.44% to reach USD 16.35 billion by 2030. Global Biologics Contract Development & Manufacturing Organization MarketBiologics contract ... Read More
-
Life Sciences BPO Market by Services (Contract Sales & Marketing Outsourcing, Medical Devices Outsourcing, Pharmaceutical Outsourcing), Application (Medical Devices, Pharmaceutical & Biopharmaceuticals) - Global Forecast 2024-2030
... USD 387.64 billion in 2023 and expected to reach USD 423.92 billion in 2024, at a CAGR 9.49% to reach USD 731.43 billion by 2030. Global Life Sciences BPO Market FPNV Positioning Matrix The FPNV ... Read More
-
Biotechnology Instrumentation Market by Product (Bioreactors, Centrifuges, Electrophoresis), End-User (Biotechnology & Biopharmaceutical Companies, Clinical Research Organizations (CROs), Government & Academic Institutes) - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 26.49 billion in 2024, at a CAGR 9.84% to reach USD 46.67 billion by 2030. Global Biotechnology Instrumentation Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Bioprocess Analyzers Market by Type (Consumables & Accessories, Instruments), Application (Antibiotics, Biosimilars, Recombinant Proteins), End User - Global Forecast 2024-2030
... to reach USD 581.42 million in 2024, at a CAGR 11.54% to reach USD 1,121.04 million by 2030. Global Bioprocess Analyzers Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Bioprocess ... Read More
-
Vasculitis Treatment Market by Drug Type (Biologics, Corticosteroids, Immunosuppressants), Disease Type (Large Vessel Vasculitis, Small & Medium Vessel Vasculitis), Distribution Channel - Global Forecast 2024-2030
... million in 2023 and expected to reach USD 202.92 million in 2024, at a CAGR 5.21% to reach USD 275.53 million by 2030. Global Vasculitis Treatment Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Biopharmaceutical Processing Equipment & Consumables Market by Product (Bioprocessing Containers, Bioreactors, Biosafety Cabinets), Application (Monoclonal Antibody, Vaccine), End-User - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 51.25 billion in 2024, at a CAGR 9.07% to reach USD 86.18 billion by 2030. Global Biopharmaceutical Processing Equipment & Consumables Market FPNV Positioning Matrix The FPNV ... Read More
-
Biosimilars Market by Product (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Recombinant Peptides), Indication (Autoimmune Diseases, Blood Disorders, Chronic Diseases), Manufacturing - Global Forecast 2024-2030
... 2023 and expected to reach USD 49.91 billion in 2024, at a CAGR 23.31% to reach USD 176.48 billion by 2030. Global Biosimilars Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Protein Engineering Market by Type (Coagulation Factors, Colony-Stimulating Factors, Erythropoietins), Product & Service (Consumables, Instruments, Software & Services), Technology, End-User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 4.16 billion in 2024, at a CAGR 10.21% to reach USD 7.49 billion by 2030. Global Protein Engineering Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Erythropoietin Stimulating Agents Market by Type (Darbepoetin Alfa, Epoetin Alfa, Epoetin Beta), Application (Anemia, Antiretroviral Treatment, Cancer Chemotherapy) - Global Forecast 2024-2030
... 2023 and expected to reach USD 10.32 billion in 2024, at a CAGR 5.64% to reach USD 14.45 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Erythropoietin Stimulating ... Read More
-
Biosimilar Monoclonal Antibodies Market by Drug Class (Abciximab, Adalimumab, Bevacizumab), Application (Diagnostic, Protein Purification, Therapeutic) - Global Forecast 2024-2030
... to reach USD 9.47 billion in 2024, at a CAGR 23.19% to reach USD 33.14 billion by 2030. Global Biosimilar Monoclonal Antibodies Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Single-use Bioprocessing Market by Function (Cell Culture, Filtration, Mixing), Product (Bioprocess Drums Liners & Accessories, Disposable Mixers, Disposable or Single-Use Bioreactors), Workflow, End-User - Global Forecast 2024-2030
... USD 39.88 billion in 2023 and expected to reach USD 53.24 billion in 2024, at a CAGR 33.58% to reach USD 302.73 billion by 2030. Global Single-use Bioprocessing Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Wound Biologics Market by Product (Biologic Skin Substitutes, Topical Agents), Wound Type (Burns, Surgical and Traumatic Wounds, Ulcers), End-User - Global Forecast 2024-2030
... 2023 and expected to reach USD 5.43 billion in 2024, at a CAGR 9.99% to reach USD 9.70 billion by 2030. Global Wound Biologics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
TNF Inhibitors Market by Product (Biosimilars, Cimzia, Enbrel), Application (Ankylosing Spondylitis, Crohn’s Disease, Hidradenitis Suppurativa) - Global Forecast 2024-2030
... reach USD 36.15 billion in 2024, at a CAGR 6.92% to reach USD 54.06 billion by 2030. Global TNF Inhibitors Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the TNF Inhibitors ... Read More
-
Biopharmaceutical Third Party Logistics Market by Supply Chain (Cold Chain, Non-Cold Chain), Service Type (Transportation, Warehousing & Storage) - Global Forecast 2024-2030
... in 2023 and expected to reach USD 121.77 billion in 2024, at a CAGR 14.20% to reach USD 271.32 billion by 2030. Global Biopharmaceutical Third Party Logistics Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Biopharmaceuticals Contract Manufacturing Market by Product (Biologics, Biosimilar), Source (Mammalian, Microbial-Based Biologics or Non-Mammalian), Contract Type, Service, Scale of Operation, Therapeutic Applications - Global Forecast 2024-2030
... USD 37.49 billion in 2023 and expected to reach USD 43.43 billion in 2024, at a CAGR 16.34% to reach USD 108.17 billion by 2030. Global Biopharmaceuticals Contract Manufacturing Market FPNV Positioning Matrix The FPNV ... Read More
-
Global Markets for Generic Drugs
... report covers small molecule drugs and biosimilars. It includes market drivers and challenges in the generic drug industry. The competitive landscape includes generic drug sales of key competitors and their ranking in the market. It ... Read More
-
Bio-Pharmaceutical Logistics Global Market Report 2024
... Application: Ground Shipping; Sea Shipping; Air Shipping5) By End Users: Pharmaceuticals; Biopharmaceuticals; Pharmacies; Hospitals; Clinics; SupermarketsCovering: Kuehne + Nagel International AG; FedEx Corporation; SF Express Co. Ltd.; Dalsey Hillblom and Lynn; Kerry Logistics Network Limited ... Read More
-
Global Biosimilars Market Research Report 2024(Status and Outlook)
... standards of pharmaceutical quality, safety and efficacy that apply to all biological medicines. Biosimilars are officially approved versions of original ""innovator"" products and can be manufactured when the original product's patent expires. Reference to the ... Read More
-
Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Research Report 2024(Status and Outlook)
... microbial testing, cell and molecular testing, and analytic testing. Health authorities such as the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) require all biopharmaceutical products and vaccines to undergo stringent ... Read More
-
Global Adalimumab Monoclonal Antibody Biosimilar Market Research Report 2024(Status and Outlook)
... The Global Adalimumab Monoclonal Antibody Biosimilar Market Size was estimated at USD 473.99 million in 2023 and is projected to reach USD 960.91 million by 2029, exhibiting a CAGR of 12.50% during the forecast period. ... Read More
-
Global Biopharmaceutical (Biopharma) Autoclaves Market Research Report 2024(Status and Outlook)
... by 2029, exhibiting a CAGR of 4.60% during the forecast period. This report provides a deep insight into the global Biopharmaceutical (Biopharma) Autoclaves market covering all its essential aspects. This ranges from a macro overview ... Read More
-
Global Single-Use Technology for Biopharmaceuticals Market Research Report 2024(Status and Outlook)
... Market Size was estimated at USD 4819.00 million in 2023 and is projected to reach USD 8490.69 million by 2029, exhibiting a CAGR of 9.90% during the forecast period. This report provides a deep insight ... Read More
-
Biosimilars Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... of Biosimilars in the Healthcare Industry Drives Revenue • High Manufacturing Costs Pose Challenges for Market Growth The global biosimilars market is on a remarkable growth trajectory during forecast period. It is expected to reach ... Read More
-
Peptide And Oligonucleotide CDMO Market Size, Share & Trends Analysis Report By Product (Peptides, Oligonucleotides), By Service Type, By End Use (Pharmaceutical Companies, Biopharmaceutical Companies), By Region, And Segment Forecasts, 2024 - 2030
... Oligonucleotide CDMO Market Growth & Trends The global peptide and oligonucleotide CDMO market is expected to reach USD 5.67 billion by 2030, according to a new report by Grand View Research, Inc. , registering a ... Read More
-
Upstream Bioprocessing Market Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Bioreactors/Fermenters, Cell Culture, Filters, Bags and Containers, and Others), Workflow (Media Preparation, Cell Culture, and Cell Separation), Usage Type (Single Use and Multiuse), Mode (In-House and Outsourced), and Geography
... Cell Culture, and Cell Separation), Usage Type (Single Use and Multiuse), Mode (In-House and Outsourced), and Geography The global upstream bioprocessing market is expected to reach US$ 25.046 billion in 2030 from US$ 9.174 billion ... Read More
Research Assistance
